Evonik and Phathom Pharmaceuticals sign supply agreement for vonoprazan

Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals to produce commercial quantities of the drug substance vonoprazan at its sites in Tippecanoe, Indiana, USA and Dossenheim, Germany. The agreement was announced on October 10, 2022.

“Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals... to produce large-scale volumes of vonoprazan.”prnewswire.co.uk

• 1 source
• prnewswire.co.ukEvonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazanEvonik Industries AGOct 10, 2022

Summarized from public sources; check the original articles before acting on it.